Michael F Mahoney Boston Scientific Corp (BSX) insider trading activity

Michael F Mahoney is Chairman, President & CEO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 1.48 Million shares of BSX, which is worth approximately $147 Million. The most recent transaction as insider was on Jan 01, 2022, when has been sold 60,635 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.48M

10.67% 3M change

11.77% 12M change

Total Value Held $147 Million

Michael F Mahoney Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2022	BUY Exercise of conversion of derivative security	-	60,635 Added 2.8%	2,107,557 Common Stock
Nov 12 2021	SELL Bona fide gift	-	34,900 Reduced 1.68%	2,046,922 Common Stock
Nov 01 2021	SELL Open market or private sale	$8,654,858 $43.05 p/Share	201,042 Reduced 8.81%	2,081,822 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$1,375,127 $6.84 p/Share	201,042 Added 8.09%	2,282,864 Common Stock
Oct 04 2021	SELL Open market or private sale	$8,626,712 $42.91 p/Share	201,042 Reduced 8.81%	2,081,822 Common Stock
Oct 04 2021	BUY Exercise of conversion of derivative security	$1,375,127 $6.84 p/Share	201,042 Added 8.09%	2,282,864 Common Stock
Sep 07 2021	SELL Open market or private sale	$8,960,397 $44.57 p/Share	201,041 Reduced 8.81%	2,081,822 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$1,375,120 $6.84 p/Share	201,041 Added 8.09%	2,282,863 Common Stock
Aug 02 2021	SELL Open market or private sale	$9,195,707 $45.74 p/Share	201,043 Reduced 8.81%	2,081,822 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$1,375,134 $6.84 p/Share	201,043 Added 8.09%	2,282,865 Common Stock
Jul 06 2021	SELL Open market or private sale	$8,727,190 $43.41 p/Share	201,041 Reduced 8.81%	2,081,822 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$1,375,120 $6.84 p/Share	201,041 Added 8.09%	2,282,863 Common Stock
May 14 2021	SELL Bona fide gift	-	34,965 Reduced 1.65%	2,081,822 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$315,281 $38.78 p/Share	8,130 Reduced 0.38%	2,116,787 Common Stock
Feb 28 2021	BUY Exercise of conversion of derivative security	-	18,330 Added 0.86%	2,124,917 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$402,937 $39.2 p/Share	10,279 Reduced 0.49%	2,106,587 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	23,175 Added 1.08%	2,116,866 Common Stock
Feb 21 2021	SELL Payment of exercise price or tax liability	$283,780 $38.03 p/Share	7,462 Reduced 0.36%	2,093,691 Common Stock
Feb 21 2021	BUY Exercise of conversion of derivative security	-	16,824 Added 0.79%	2,101,153 Common Stock
Feb 18 2021	SELL Payment of exercise price or tax liability	$271,345 $37.52 p/Share	7,232 Reduced 0.35%	2,084,329 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	-	16,306 Added 0.77%	2,091,561 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$314,261 $38.39 p/Share	8,186 Reduced 0.39%	2,075,255 Common Stock
Feb 15 2021	BUY Exercise of conversion of derivative security	-	18,457 Added 0.88%	2,083,441 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$1,240,247 $38.85 p/Share	31,924 Reduced 1.52%	2,064,984 Common Stock
Feb 10 2021	BUY Grant, award, or other acquisition	-	71,981 Added 3.32%	2,096,908 Common Stock

Also insider at

BAX

BAXTER INTERNATIONAL INC Healthcare

Director

CVS

CVS HEALTH Corp Healthcare

Director

MFM